DEUTSCHE BANK AG\
BankPosition in ACRS — Aclaris Therapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in ACRS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$3,741,937
+$770,011 QoQ
Shares Held
997,850
+1.1% QoQ
Ownership
0.714%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. ACRS ranks #79 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in ACRS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,741,937 | 997,850 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,971,926 | 987,351 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,754,294 | 923,313 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,429,299 | 1,006,549 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,412,668 | 923,313 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,289,816 | 923,313 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $1,061,809 | 923,313 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $1,015,644 | 923,313 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $1,186,705 | 957,021 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $980,747 | 934,046 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,057,015 | 154,309 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $11,268,248 | 1,086,620 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,916,772 | 1,102,197 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $18,547,089 | 1,177,593 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,398,437 | 1,168,897 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,398,825 | 1,174,701 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $25,292,854 | 1,467,103 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,694,191 | 254,071 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $5,803,902 | 322,439 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $5,869,147 | 334,234 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $6,519,517 | 258,711 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $424,613 | 65,628 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $168,663 | 65,628 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $106,317 | 65,628 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $40,583 | 39,023 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||